Please wait while the formulary information is being retrieved.
CHILDREN'S ZYRTEC ALLERGY (cetirizine HCl)
- inflammation of the nose due to an allergy
- persistent hives of unknown cause
- non-seasonal allergic stuffy and runny nose
- seasonal runny nose
10 mg disintegrating tablet
- Dosage information is not available
10 mg disintegrating tablet
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Chronic kidney disease stage 5 (failure) GFr<15 ml/min
Severe
Moderate
- Disease of liver
- Glaucoma
- Urinary retention
CHILDREN'S ZYRTEC ALLERGY (cetirizine HCl)
- inflammation of the nose due to an allergy
- persistent hives of unknown cause
- non-seasonal allergic stuffy and runny nose
- seasonal runny nose
- None
- Drowsy
- Dry nose
- Dry throat
- Xerostomia
More Frequent
Severe
Less Severe
- None
- Acute abdominal pain
- Diarrhea
- Epistaxis
- Fatigue
- Insomnia
- Nausea
- Pharyngitis
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute generalized exanthematous pustulosis
- Anaphylaxis
- Bronchospastic pulmonary disease
- Cardiac arrhythmia
- Cholestasis
- Dehydration
- Edema
- Hearing loss
- Hepatitis
- Palpitations
- Seizure disorder
- Tongue swelling
- Tonic clonic seizure
Less Severe
- Acne vulgaris
- Acute cognitive impairment
- Alopecia
- Anorexia
- Anticholinergic toxicity
- Blurred vision
- Constipation
- Cramps in legs
- Dizziness
- Dysgeusia
- Dyskinesia
- Dyspepsia
- Dysuria
- Eructation
- Excitement
- Flatulence
- Gastritis
- Hallucinations
- Headache disorder
- Hemorrhoids
- Hyperhidrosis
- Increased appetite
- Memory impairment
- Nervousness
- Nightmares
- Parosmia
- Skin photosensitivity
- Skin rash
- Stomatitis
- Syncope
- Tachycardia
- Tinnitus
- Tongue discoloration
- Tremor
- Unsteady gait
- Urinary retention
- Visual changes
- Vomiting
- Weight gain
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Cetirizine (Oral, IV)
Safety and efficacy not established in infants age <6 months.
- 1 Day – 179 Days
- Safety and efficacy not established in infants age <6 months.
Cetirizine
- Severity Level:
2
- Additional Notes: Insufficient human data available on developmental toxicity risk
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Cetirizine
Probably compatible: may cause sedation in nursing infant.
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Excreted | Not known; no or inclusive data | Probably compatible: may cause sedation in nursing infant. |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
Cetirizine
Increased risk for neurological side effects. Dosage adjustment may be required.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | Y | N | N | Y | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
Allergic rhinitis | |
J30.1 | Allergic rhinitis due to pollen |
J30.2 | Other seasonal allergic rhinitis |
J30.5 | Allergic rhinitis due to food |
J30.8 | Other allergic rhinitis |
J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
J30.89 | Other allergic rhinitis |
J30.9 | Allergic rhinitis, unspecified |
Chronic idiopathic urticaria | |
L50.1 | Idiopathic urticaria |
Perennial allergic rhinitis | |
J31.0 | Chronic rhinitis |
Seasonal allergic rhinitis | |
J30.1 | Allergic rhinitis due to pollen |
J30.2 | Other seasonal allergic rhinitis |
0-9 | A-Z |
---|---|
J30.1 | Allergic rhinitis due to pollen |
J30.1 | Allergic rhinitis due to pollen |
J30.2 | Other seasonal allergic rhinitis |
J30.2 | Other seasonal allergic rhinitis |
J30.5 | Allergic rhinitis due to food |
J30.8 | Other allergic rhinitis |
J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
J30.89 | Other allergic rhinitis |
J30.9 | Allergic rhinitis, unspecified |
J31.0 | Chronic rhinitis |
L50.1 | Idiopathic urticaria |
Formulary Reference Tool